FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to a composition for treating dermatologic diseases, preferentially skin itching. The composition causes antiallergic action and is used in treating allergic reactions (rash, urticaria), insect bites, ultraviolet erythema and skin burns. The pharmaceutical composition contains azelastine hydrochloride and benzocaine as active substances, and a hydrophobic ingredient, a hydrophilic ingredient, an emulsifying agent and a pH corrective agent as additive agents. As the pH corrective agent, the composition contains preferentially succinic acid. The pharmaceutical composition is presented as a soft dosage form, preferentially in the form of a cream.
EFFECT: composition according to the invention is characterised by high pharmacologic activity, good package extrusion, and storage-stability.
9 cl, 1 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT CONTAINING COMBINATION OF ACTIVE SUBSTANCES CONTAINING PANTOTHENIC ACID OR ITS DERIVATIVES FOR TREATING ALLERGIC SYMPTOMS | 2008 |
|
RU2472499C2 |
| GEL, POSSESSING ANTI- INFLAMMATORY AND ANTIALLERGIC EFFECT | 2008 |
|
RU2370265C1 |
| METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION WITH FEXOFENADINE, PROVIDING ANTI-ALLERGIC AND ANTI-INFLAMMATORY EFFECT | 2015 |
|
RU2614961C1 |
| NEW COMBINATION OF ANTI-HISTAMINE AGENTS HAVING NO SEDATIVE ACTION WITH COMPOUNDS EFFECTING TO LEUKOTRIEN ACTION FOR RHINITIS/CONJUNCTIVITIS TREATMENT | 2001 |
|
RU2292208C2 |
| METHOD OF TREATING DERMATITIS IN ANIMALS | 2015 |
|
RU2601895C1 |
| PHARMACEUTICAL COMPOSITION OF ANTIALLERGIC AND ANTI-INFLAMMATORY ACTION FOR INTRANASAL APPLICATION | 2019 |
|
RU2736082C1 |
| PARALYTIC SHELLFISH POISON | 2013 |
|
RU2633637C2 |
| USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS | 2014 |
|
RU2666219C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DERMATOSES THAT CAN BE TREATED BY GLUCOCORTICOSTEROID THERAPY, AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2396081C1 |
| ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
